Substrate specificity of rat sera IgG antibodies with peroxidase and oxidoreductase activities

Journal of Molecular Recognition

Volumn 19, Issue 5, 2006, Pages 432-440

  Ikhmyangan, Erdenechimeg N ^a,b   Vasilenko, Nataliya L ^b   Sinitsina, Ol'ga I ^a   Buneva, Valentina N ^b   Nevinsky, Georgy A ^a,b  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

Author keywords

Abzyme; IgG; Oxidoreductase and peroxidase activities; Sera of healthy rats; Substrate specificities

Indexed keywords

HORSERADISH PEROXIDASE; IMMUNOGLOBULIN G; METAL; NAPHTHOL DERIVATIVE; PHENOL;

ANIMAL; ARTICLE; BLOOD; ENZYME SPECIFICITY; GEL CHROMATOGRAPHY; KINETICS; LIQUID CHROMATOGRAPHY; METABOLISM; OXIDATION REDUCTION REACTION; RAT; WISTAR RAT;

ANIMALS; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, LIQUID; HORSERADISH PEROXIDASE; IMMUNOGLOBULIN G; KINETICS; METALS; NAPHTHOLS; OXIDATION-REDUCTION; PHENOL; RATS; RATS, WISTAR; SUBSTRATE SPECIFICITY;

ARMORACIA RUSTICANA; MAMMALIA; RATTUS NORVEGICUS;

EID: 33748921452     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.787     Document Type: Article

References (46)

1. Allen RG. 1993. Free radicals in aging. CPC Press: Boca Raton, FL; pp. 12-23.
2. Ames BN. 1983. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221: 1256-1264.
3. Andrievskaia OA, Buneva VN, Zabara VG, Naumov VA, Iamkovoi VI, Nevinskii GA. 1998. RNA-hydrolyzing antibodies from peripheral blood of patients with lupus erythematosus. Mol. Biol. (Moscow) 32: 908-915.
4. Andrievskaya OA, Buneva VN, Naumov VA, Nevinsky GA. 2000. Catalytic heterogeneity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus. Med. Sci. Monit. 6: 460-470.
5. Baranovskii AG, Kanyshkova TG, Mogelnitskii AS, Naumov VA, Buneva VN, Gusev EI, Boiko AN, Zargarova TA, Favorova OO, Nevinsky GA. 1998. Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyse DNA and RNA. Biochemistry (Moscow) 63: 1239-1248.
6. Baranovsky AG, Matushin VG, Vlassov AV, Zabara VG, Naumov VA, Giege R, Buneva VN, Nevinsky GA. 1997. DNA- and RNA-hydrolyzing antibodies from the blood of patients with various forms of viral hepatitis. Biochemistry (Moscow) 62: 1358-1366.
7. Beckman KB, Ames BN. 1998. The free radical theory of Aging Matures. Physiol Rev. 78: 547-581.
8. Buneva VN, Kudryavtseva AN, Gal'vita AV, Dubrovskaya VV. Khokhlova OV, Kalinina IA, Galenok VA, Nevinsky GA. 2003. Dynamics of antibody nuclease activity in blood of women during pregnancy and lactation. Biochemistry (Moscow) 68: 890-900.
9. Catalytic antibodies. 2005. Keinan EE (ed.). Wiley-VCH Verlag GmbH and Co.: KgaA, Germany, pp. 1-586.
10. Ceballos-Picot I, Nicole A, Clement M, Bourre JM, Sinet PM. 1992. Age-related changes in antioxidant enzymes and lipid peroxidation in brains of control and transgenic mice overexpressing copper-zinc superoxide dismutase. Mutat Res. 275: 281-293.
11. Dietz KJ. 2003. Plant peroxiredoxins. Annu. Rev. Plant Biol. 54: 93-107.
12. Ding L, Liu Z, Zhu Z, Luo G, Zhao D, Ni J. 1998. Biochemical characterization of selenium-containing catalytic antibody as a cytosolic glutathione peroxidase mimic. Biochem. J. 332: 251-255.
13. Fersht A. 1977. Enzyme Structure and Mechanism. 2nd ed., W. H. Freeman, Co.: NY.
14. Generalov II, Novikov DK, Zhiltsov IV. 1999. Catalytic activity of antibodies. Vestsi Natsyyanal'nai Akademii Navuk Belarusi. Seryya Biyalagichnykh Navuk. 1: 90-96.
15. Gololobov G, Tramontano A, Paul S. 2000. Nucleophilic proteolytic antibodies. Appl. Biochem. Biotechnol. 83: 221-231.
16. Ikhmyangan EN, Vasilenko NL, Buneva VN, Nevinsky GA. 2005. IgG antibodies with peroxidase-like activity from the sera of healthy Wistar rats. FEBS Lett. 579: 3960-3964.
17. Ikhmyangan EN, Vasilenko NL, Buneva VN, Nevinsky GA. 2006. Metal ions-dependent peroxidase and oxidoreductase activities of polyclonal IgGs from the sera of Wistar rats. J. Mol. Recognit.; Jan 16.
18. Kalaga R, Li L, O'Dell JR, Paul S. 1995. Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J. Immunol. 155: 2695-2702.
19. Kulberg AY, Petyaev IM, Zamotaeva NG. 1988. Catalytic properties of catabolic destruction of cell receptors (R-proteins). Immunology (Moscow) 3: 37-40.
20. Lacroix-Desmazes S, Bayry J, Kaveri SV, Hayon-Sonsino D, Thorenoor N, Charpentier J, Luyt CE, Mira JP, Nagaraja V, Kazatchkine MD, Dhainaut JF, Mallet VO. 2005. High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc. Natl. Acad. Sci. USA 102: 4109-4113.
21. Mahy JP, Desfosses B, de Lauzon S, Quilez R, Desfosses B, Lion L, Mansuy D. 1998. Different strategies for obtaining artificial hemoproteins based on antibodies. Appl. Biochem. Biotechnol. 75: 103-127.
22. Mates JM, Sanchez-Jimenez F. 1999b. Antioxidant enzymes and their implications in pathophysiologic processes. Front. Biosci. 4: D339-345.
23. Mates JM, Perez-Gomez C, Nunez de Castro I. 1999a. Antioxidant enzymes and human diseases. Clin. Biochem. 32: 595-603.
24. Nevinsky GA, Buneva VN. 2002a. Human catalytic RNA- and DNA-hydrolyzing antibodies. J. Immunol. Methods 269: 235-249.
25. Nevinsky GA, Buneva VN. 2003. Catalytic antibodies in healthy humans and patients with autoimmune and viral pathologies. J. Cell. Mol. Med. 7: 265-276.
26. Nevinsky GA, Buneva VN. 2005. Natural catalytic antibodies-abzymes. In Catalytic antibodies. Keinan E (ed.). VCH-Wiley press: Germany, pp. 503-567.
27. Nevinsky GA, Semenov DV, Buneva VN. 2000a. Catalytic antibodies (abzymes) induced by stable transition-state analogs. Biochemistry (Moscow) 65: 1459-1472.
28. Nevinsky GA, Kanyshkova TG, Semenov DV, Vlassov AV, Gal'vita AV, Buneva VN. 2000b. Secretory immunoglobulin A from healthy human mothers' milk catalyzes nucleic acid hydrolysis. Appl. Biochem. Biotechnol. 83: 115-129.
29. Nevinsky GA, Favorova OO, Buneva VN. 2002b. Catalytic antibodies: New characters in the protein repertoire. Protein-protein interactions. A molecular cloning manual. Cold Spring Harbor: NY, 523-534.
30. Odintsova ES, Buneva VN, Nevinsky GA. 2005. Casein-hydrolyzing activity of sIgA antibodies from human milk. J. Mol. Recognit. 18: 413-421.
31. Paul S, Volle DJ, Beach CM, Johnson DR, Powell MJ, Massey RJ. 1989. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science 244: 1158-1162.
32. Polosukhina DI, Kanyshkova TG, Doronin BM, Tyshkevich OB, Buneva VN, Boiko AN, Gusev EI, Favorova OO, Nevinsky GA. 2004. Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis. J. Cell. Mol. Med. 8: 359-368.
33. Quilez R, de Lauzon S, Desfosses B, Mansuy D, Mahy JP. 1996. Artificial peroxidase-like hemoproteins based on antibodies constructed from a specifically designed ortho-carboxy substituted tetraarylporphyrinhapten and exhibiting a high affinity for iron-porphyrins. FEBS Lett. 395: 73-76.
34. Ren X, Gao S, You D, Huang H, Liu Z, Mu Y, Liu J, Zhang Y, Yan G, Luo G, Yang T, Shen J. 2001. Cloning and expression of a single-chain catalytic antibody that acts as a glutathione peroxidase mimic with high catalytic efficiency. Biochem J. 359: 369-374.
35. Savel'ev AN, Kanyshkova TG, Kulminskaya AA, Buneva VN, Eneyskaya EV, Filatov MV, Nevinsky GA, Neustroev KN. 2001. Amylolytic activity of IgG and sIgA immunoglobulins from human milk. Clin. Chim. Acta. 314: 141-152.
36. Saveliev AN, Ivanen DR, Kulminskaya AA, Ershova NA, Kanyshkova TG, Buneva VN, Mogelnitskii AS, Doronin BM, Favorova OO, Nevinsky GA, Neustroev K. 2003. Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis. Immunol. Lett. 86: 291-297.
37. Semenov DV, Kanyshkova TG, Karotaeva NA, Krasnorutskii MA, Kuznetsova IA, Buneva VN, Nevinsky GA. 2004. Catalytic nucleotide-hydrolyzing antibodies in milk and serum of clinically healthy human mothers. Med. Sci. Monit. 10: BR23-BR33.
38. Shuster AM, Gololobov GV, Kvashuk OA, Bogomolova AE, Smirnov IV, Gabibov AG. 1992. DNA hydrolyzing autoantibodies. Science 256: 665-667.
39. Su D, Ren X, You D, Li D, Mu Y, Yan G, Zhang Y, Luo Y, Xue Y, Shen J, Liu Z, Luo G. 2001. Generation of three selenium-containing catalytic antibodies with high catalytic efficiency using a novel hapten design method. Arch Biochem Biophys. 395: 177-184.
40. Tian L, Cai Q, Wei H. 1998. Alterations of antioxidant enzymes and oxidative damage to macromolecules in different organs of rats during aging. Free Radic Biol Med 24: 1477-1484.
41. Vlassov A, Florentz C, Helm M, Naumov V, Buneva V, Nevinsky G, Giege R. 1998. Characterization and selectivity of catalytic antibodies from human serum with RNAse activity. Nucleic Acid Research 26: 5243-5250.
42. Wentworth AD, Jones LH, Wentworth P Jr, Janda KD, Lerner RA. 2000. Antibodies have the intrinsic capacity to destroy antigens. Proc. Natl. Acad. Sci. USA 97: 10930-10935.
43. Wentworth PJr, Jones LH, Wentworth AD, Zhu X, Larsen NA, Wilson IA, Xu X, Goddard WA, 3rd, Janda KD, Eschenmoser A, Lerner RA. 2001. Antibody catalysis of the oxidation of water. Science 293: 1806-1811.
44. Zenkov NK, Lankin VZ, Men'shikova EB. 2001. Oxidative stress. Biochemical and pathophysiological aspects. MAIK: Nauka/ Interperiodica, Moscow. pp. 3-343.
45. Zhang Y, Li ZS, Sun M, Zheng QC, Sun CC. 2005. Molecular simulation studies of a selenium-containing scFv catalytic antibody that mimics glutathione peroxidase. Biochim Biophys Acta. 1747: 27-34.
46. Zhil'tsov IV, Generalov II, Dotsenko ML, Matveev AA. 1998. The enzymatic activity of IgG preparations in viral hepatitis. Zh. Mikrobiol. Epidemiol. Immunobiol. 4: 73-77.